Advertisement
Legal/Regulatory
Subscribe to Legal/Regulatory

The Lead

Quintiles, Quest to Join to Provide Global Clinical Trials Lab Services

March 31, 2015 11:38 am | News | Comments

Quintiles and Quest Diagnostics announced a definitive agreement to form a global clinical trials laboratory services business. Read more...

Arizona Governor Signs Abortion Drug Notification Mandate

March 31, 2015 11:22 am | by Bob Christie and Ryan Van Velzer, Associate Press | News | Comments

Gov. Doug Ducey signed a bill Monday that requires abortion providers in Arizona to tell women...

Merck Serono, Intrexon Agree to Develop, Commercialize CAR-T Therapy

March 31, 2015 10:21 am | News | Comments

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation announced an...

Britain to Offer All Infants Meningitis B Vaccine

March 31, 2015 10:17 am | by Associated Press | News | Comments

Britain says it will become the first country to offer all babies a vaccine for potentially...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Development, Commercialization of Antibacterial Drugs to Speed Up

March 31, 2015 10:12 am | News | Comments

The growing threat posed by multi-drug resistant gram-negative organisms (MDR-GNBs) is lending a sense of urgency to the development of antibacterial drugs worldwide. Upcoming regulatory reforms to lower R&D costs and provide incentives for new drug identification will create attractive opportunities for pharmaceutical manufacturers. Read more...

Novartis, Aduro: Up-to-$750M Cancer Immunotherapy Collaboration

March 30, 2015 12:52 pm | by Stephanie Guzowski, Editor | News | Comments

Novartis is planning to boost its cancer immunotherapy pipeline with a collaboration with California-based Aduro Biotech worth up to $750 million. Read more...

Colleges Getting Out of Health Insurance Business

March 29, 2015 3:05 pm | by Donna Gordon Blankinship, Associated Prss | News | Comments

The federal health care overhaul is leading some colleges and universities to get out of the health insurance business. Read more...

Advertisement

Answers to Common Questions about HIV, Needles, and Drug Use

March 27, 2015 1:47 pm | by Carla K. Johnson, AP Medical Writer | News | Comments

Indiana Gov. Mike Pence has authorized a short-term needle-exchange program and other steps to help contain the spread of HIV among intravenous drug users in one county. Read more...

White House Releases Plan to Fight Antibiotic Resistance

March 27, 2015 12:58 pm | by Stephanie Guzowski, Editor | News | Comments

The White House has revealed today its comprehensive plan to tackle antibiotic resistance within the next five years, according to a copy of the 60-page report, which was reviewed by Reuters. Read more...

Indiana Governor Overrides Law to Authorize Needle Exchange

March 27, 2015 10:32 am | by Rick Callahan, AP | News | Comments

Indiana Gov. Mike Pence overrode state law and his own anti-drug policies Thursday to authorize a short-term needle-exchange program designed to help contain HIV infections in a rural county where more than six dozen cases have been reported, all of them tied to intravenous drug use. Read more...

Gelesis Closes $22M Equity Financing

March 27, 2015 10:21 am | News | Comments

Gelesis, a clinical stage biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, announced today that it closed an equity financing of shares of convertible preferred stock for gross proceeds of approximately $22 million. Read more...

Novo Nordisk Resubmits NDA for Tresiba, Ryzodeg in U.S.

March 26, 2015 4:38 pm | News | Comments

The resubmission is expected to take place within the next month. Read more...

Advertisement

Takeda's NDA for Type 2 Diabetes Drug Gets Japanese Approval

March 26, 2015 4:26 pm | News | Comments

Zafatek is a once-weekly DPP-4 inhibitor. Read more...

Multistate Investigation Announced into Premera Cyberattack

March 26, 2015 2:10 pm | by Derrick Nunnally, Associated Press | News | Comments

Washington state's insurance commissioner announced a multistate investigation into this winter's cyberattack on Premera Blue Cross. Read more...

FDA to Scrutinize Unproven Alternative Remedies

March 26, 2015 12:42 pm | by Matthew Perrone, AP Health Writer | News | Comments

Federal officials plan to review the safety and evidence behind alternative remedies like Zicam and Cold-Eeze, products that are protected by federal law, but not accepted by mainstream medicine. Read more...

Germany's Pharmaceutical Market Value will Crawl to $65B by 2020

March 26, 2015 11:38 am | by Joshua Owide, Director of Healthcare Industry Dynamics, GlobalData | Articles | Comments

Germany is a mature market with high healthcare expenditure and pharmaceutical production. Read more...

GSK Gains Japanese Approval for COPD Therapy

March 26, 2015 8:25 am | News | Comments

Following this approval, it is expected that launch will take place in Japan in 2015. Read more...

Advertisement

Biocept Enters Clinical Collaboration With UC, San Diego Moores Cancer Center

March 25, 2015 9:42 am | News | Comments

Biocept, Inc., a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), announced that it has entered into a clinical collaboration with University of California, San Diego Moores Cancer Center.

Blueprint Medicine Files for IPO

March 25, 2015 9:30 am | by Ryan Bushey, Associate Editor | Articles | Comments

The biotech firm is making a big bet on the success of its precision therapies. Read more...

Pfizer, Lilly To Resume Phase 3 Chronic Pain Program For Tanezumab

March 24, 2015 12:37 pm | News | Comments

Pfizer Inc. and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical program for tanezumab. Read more...

Bristol-Myers Acquires Novo License for Autoimmune Diseases Research Program

March 24, 2015 12:33 pm | News | Comments

Bristol-Myers Squibb Company announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases. Read more...

Gilead Issues Safety Alert over Hepatitis C, Heart Drug Combination

March 24, 2015 12:03 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Taking these medications together is ill-advised. Read more...

WHO Denies Politics Swayed Ebola Emergency Declaration

March 24, 2015 8:40 am | by Maria Cheng and Raphael Satter, Associated Press | News | Comments

The World Health Organization denied Monday that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year. Read more...

Scientists Win $1.5 Million Grant to Develop New Cancer Drugs

March 23, 2015 10:14 am | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $1.5 million grant from the National Institutes of Health (NIH) to develop drug candidates that could treat cancer and neurodegenerative disease. Read more..

US Anti-Drugs Work in Colombia Uses Cancer-Linked Herbicide

March 23, 2015 8:24 am | by Joshua Goodman, Associated Press | News | Comments

New labeling on the world's most popular weed killer as a likely cause of cancer is raising more questions for an aerial spraying program in Colombia that underpins U.S.-financed efforts to wipe out cocaine crops. Read more...

Officials Urge Meningitis Shots at University of Oregon

March 20, 2015 10:16 am | by Jeff Barnard, Associated Press | News | Comments

More than half of the undergraduates at the University of Oregon have not been vaccinated against meningitis, despite the fact that one student has died and five others have been sickened since January. Read more...

AbbVie, C2N Enter Into License Agreement For Alzheimer's Therapy

March 19, 2015 4:17 pm | News | Comments

​AbbVie announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders. Read more....

Provisions for Hepatitis C Drugs Overseas Causes Controversy

March 19, 2015 2:22 pm | by Ryan Bushey, Associate Editor | Articles | Comments

A famous medical nonprofit is concerned about how these drugs will be distributed overseas. Read more...

Why People with Diabetes Can't Buy Generic Insulin

March 19, 2015 1:20 pm | by Johns Hopkins University | News | Comments

A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014. Read more..

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading